| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/28/2004 | EP1058555B1 Costimulatory blockade and mixed chimerism in allotransplantation |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0655925B1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1492765A Herbal composition for preventing and treatment of dementia |
| 04/28/2004 | CN1492764A Medicines for relieving intestinal disorders |
| 04/28/2004 | CN1491963A Live scorpion active protein having anti-epilepsy function, preparing method and use |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1491701A Medicine for treating sympthetic nerve disorder |
| 04/28/2004 | CN1491668A Composition of stachyose and bee product |
| 04/28/2004 | CN1491667A Use of Euproctis pseudoconspersa in preparing medicine for treating diseases of gastrointestinal tract |
| 04/28/2004 | CN1491666A Chinese patented medicine for treating cholecystitis and its preparing method |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/28/2004 | CN1491584A Chewing tablet of pilose antler |
| 04/28/2004 | CN1147313C Orally applied medicine for treating arthropathy and its preparing process |
| 04/28/2004 | CN1147311C External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation |
| 04/28/2004 | CN1147310C Chinese-medicinal skin-protecting product |
| 04/28/2004 | CN1147309C Medicine for treatnig heart disease and promoting recovery |
| 04/28/2004 | CN1147308C Plaster for treating bone diseases |
| 04/28/2004 | CN1147307C Medicine for curing osteomyelitis and its preparing method |
| 04/28/2004 | CN1147305C Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof |
| 04/28/2004 | CN1147291C Enteric coating, comprising alginic acid, for an oral preparation |
| 04/28/2004 | CA2447199A1 Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447190A1 Homing of donor cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447167A1 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727224 Methods and compositions for healing and repair of articular cartilage |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726935 Secreted from venom gland of a toad; formulated as ointment, suspension, gel, spray, patch or solution; for preventing premature, noncontrolled ejaculation and/or sexual hypersensitivity |
| 04/27/2004 | US6726913 Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | US6726907 Purified adenoviral compositions |
| 04/22/2004 | WO2004033729A1 Method of preserving biological materials |
| 04/22/2004 | WO2004033672A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | WO2004033665A2 Heterologous plasma cocktail for hiv treatment |
| 04/22/2004 | WO2004033635A2 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| 04/22/2004 | WO2004033620A2 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | WO2004032952A1 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 04/22/2004 | WO2004032881A2 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | WO2004032823A2 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
| 04/22/2004 | WO2004032645A1 Food additive and/or drinking water additive for domestic animals |
| 04/22/2004 | WO2004020639A3 Production of multimeric fusion proteins using a c4bp scaffold |
| 04/22/2004 | WO2004017979A3 Medicament, food supplement, and fodder additive |
| 04/22/2004 | WO2004009237A3 Sperm cell process system |
| 04/22/2004 | WO2004007696A3 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 04/22/2004 | WO2004003178A3 Decellularized tissue |
| 04/22/2004 | WO2003099312A8 Method for determining immune system affecting compounds |
| 04/22/2004 | WO2003068937A3 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 04/22/2004 | WO2003068249A8 Shark cartilage extracts and use thereof for immunomodulation |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2003022202A9 Compositions and methods for treatment of cancer |
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002062970A8 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 04/22/2004 | US20040078076 Purified submucosa graft material |
| 04/22/2004 | US20040077985 Method of replenishing cells damaged by treatment for cancer |
| 04/22/2004 | US20040077831 Methods for removing analytes such as proteins, from biological compositions such as blood; blood cells prepared in this manner remain viable following prolonged storage and are suitable for therapeutic use e.g. in transfusion applications |
| 04/22/2004 | US20040077539 Stimulating growth of lactic acid producing bacteria in gastrointestinal tract; enriched whey protein concentrate |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
| 04/22/2004 | US20040076965 MIA-2 protein |
| 04/22/2004 | US20040076945 Compositions comprising reproductive cell media and methods for using such compositions |
| 04/22/2004 | US20040076695 EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 04/22/2004 | US20040076687 Nutritional supplement containing sea water minerals |
| 04/22/2004 | US20040076657 Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
| 04/22/2004 | US20040076640 Incubating first means expressing the target receptor of an infectious pathogen, with a second means expressing a region regconizing the targets, to form a complex and contacting with a binding agent at different intervals |
| 04/22/2004 | US20040076622 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 04/22/2004 | US20040076620 Removing blood cells from mammal, expanding blood cells with stem cell factor, at least seven times in less than seven days, maintaining three-dimensional geometry, purification, detoxification, reintroducing the cells back into mammal |
| 04/22/2004 | US20040076619 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/22/2004 | US20040076618 Preparation of an animal extracts having low molecular weight less than 3 kDa, obtained from a mammalian placenta, used as anticarcinogenic agents for treating cancer |
| 04/22/2004 | US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds |
| 04/22/2004 | US20040076604 Tolergenic antigen presenting cells and in treating immune-inflammatory conditions |
| 04/22/2004 | US20040076603 Using copper chelate; for use in/ex vivo |
| 04/22/2004 | DE10136702B4 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen System for cell and developmental selection differentiating embryonic stem cells, adult stem cells and embryonic germ cells |
| 04/22/2004 | CA2501949A1 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | CA2501630A1 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | CA2501226A1 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| 04/22/2004 | CA2465860A1 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | CA2445364A1 Method for producing fish gelatin peptide |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1410803A1 MIA-2 proteins |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409653A1 Viral mutants that selectively replicate in targeted human cancer cells |
| 04/21/2004 | EP1409650A1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 04/21/2004 | EP1409648A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409643A1 Probiotic lactobacillus casei strains |
| 04/21/2004 | EP1409539A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 04/21/2004 | EP1409527A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409025A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 04/21/2004 | EP1409012A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |